Onyx Pharmaceuticals, Inc.
Officielle registerdata
0følgere
2013grundlagt
Om Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. was a pharmaceutical company headquartered in South San Francisco, California that developed and marketed cancer treatment medications. It was founded and incorporated with the California Secretary of State in February 1992 by venture capitalist Kevin J. Kinsella and Frank McCormick, Ph.D., FRS, D.Sc. (Hon.), a renowned British-American biochemist. McCormick served as the chief scientific officer until 1996, while Kinsella chaired the company's board of directors. On March 26, 1996, Onyx withdrew its corporate registration with the California Secretary of State and reincorporated in the state of Delaware in advance of successfully taking the company public on the NASDAQ exchange using National Market symbol ONXX on May 9, 1996. In 2009, the company acquired private biotechnology company Proteolix for US$276 million in cash plus additional milestone payments. In January 2012, the company was named "the top biotechnology takeover target in 2012" in an industry survey conducted by the ISI Group. Onyx president and CEO N. Anthony Coles had said that Onyx liked its prospects as an independent company and was focused on bringing new therapies to patients. However, by the end of August 2013, Amgen announced that it was acquiring Onyx in an agreed US$10.4 billion deal.
Source: Wikipedia
HovedsædeCorporation Trust Center, 1209 Orange Street, 19801, Wilmington, US
Stiftet2013
StatusAktiv
Patenter60 patenter
METHODS OF TREATING MULTIPLE MYELOMA USING BCL-2 INHIBITOREP4558143A4 · 2026
Methods of treating multiple myelomaUS12636340B2 · 2026
Log ind for at se alle 60 patenter
Gennemse hele patentporteføljen med publikationsnumre, datoer og familier.
Log ind Opret en konto med din e-mailDet er gratis
Ved at fortsætte accepterer du Heelkys Brugeraftale, Privatlivspolitik og Cookiepolitik.
Anmeldelser
Ingen anmeldelser endnu. Har du arbejdet med Onyx Pharmaceuticals, Inc.? Vær den første til at dele din oplevelse.
Juridiske oplysninger
| Juridisk navn | Onyx Pharmaceuticals, Inc. |
|---|---|
| LEI | 549300K47GO90N8J4853Vis på GLEIF ↗ |
| Registreret adresse | Corporation Trust Center, 1209 Orange Street, 19801, Wilmington, US |
| Status | Aktiv |
Kilder: GLEIF · opdateret 16. Oktober 2026
Kontakt og links
Sted
Corporation Trust Center, 1209 Orange Street, 19801, Wilmington, US
Er det din virksomhed?
Gør krav på denne side gratis for at tilføje dit logo, produkter, billeder og job og for at svare på anmeldelser.
Gør krav på denne sideBliv en del af Heelky for at skabe forbindelse, ansætte og vokse
Opret en gratis konto for at skrive til folk, søge job og oprette opgaver.
Deltag nu — det er gratis